United States · FDA National Drug Code directory
Augtyro
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0003-4040_9fa5a47f-24bf-464a-aed7-54ad81abf121
- Product NDC
- 0003-4040
- Form
- CAPSULE
- Composition / generic term
- repotrectinib
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20231205
- Source listing expiry
- 20271231
Source-listed ingredients
- REPOTRECTINIB — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 CAPSULE in 1 BOTTLE (0003-4040-12) · 0003-4040-12
- 60 CAPSULE in 1 BOTTLE (0003-4040-60) · 0003-4040-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →